Jazz Pharmaceuticals JAZZ Total Revenue
Total Revenue at other companies
Segments
Other financials
Where this comes from
Reported directly by Jazz Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: Jazz Pharmaceuticals’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Jazz Pharmaceuticals's total revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Jazz Pharmaceuticals's total revenue?
- Jazz Pharmaceuticals (JAZZ) reported total revenue of $1.07B in Q1 2026.
- How has Jazz Pharmaceuticals's total revenue changed year-over-year?
- Jazz Pharmaceuticals's total revenue increased by 19.1% year-over-year, from $897.8M to $1.07B.
- What is the long-term trend for Jazz Pharmaceuticals's total revenue?
- Over 4 years (2021 to 2025), Jazz Pharmaceuticals's total revenue has grown at a 8.4% compound annual growth rate (CAGR), from $3.09B to $4.27B.
- What does total revenue mean?
- The total amount of money brought in from sales before any expenses are subtracted.
- How do you interpret total revenue?
- An increase indicates successful product adoption or market expansion, while a decrease may signal competitive pressure or patent expirations.
- How does total revenue compare across companies?
- Standard top-line metric across all pharmaceutical and biotech companies.